Journals / JAREM / 2012 / Cilt: 2 - Sayı: 3

After radical prostatectomy erectile dysfunction: approach and penile rehabilitation treatment modalities

Radikal prostatektomi sonrası erektil disfonksiyon: yaklaşım ve penil rehabilitasyonda tedavi modaliteleri

Journal
JAREM
Pages
89–95
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The recent studies on growth factors, immunophilines, gene and stem cell treatments are promising.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Although radical prostatectomy is the golden standard treatment for organ confined prostate cancer, postoperative erectile dysfunction which can be seen after operations severely deteriorates the quality of life.
📊
Key Findings & Data:Stan- dard treatment methods such as phosphodiesterase 5 inhibitors, transurethral prostaglandin, intracavernosal injections, vacuum devices and penile prosthesis implantation have many advantages and disadvantages, and standard treatments models have indication differences.
💡
Conclusion & Impact:The recent studies on growth factors, immunophilines, gene and stem cell treatments are promising.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Although radical prostatectomy is the golden standard treatment for organ confined prostate cancer, postoperative erectile dysfunction which can be seen after operations severely deteriorates the quality of life. In this compilation, by scanning the medical literature, the erectile dysfunction, pathophysiology, prevention and treatments used in post radical prostatectomy are reviewed. An appropriate patient is crucial to prevent erectile dysfunction seen after advanced surgical techniques operations. An early rehabilitation program allows rapid correction of erectile dysfunction . Stan- dard treatment methods such as phosphodiesterase 5 inhibitors, transurethral prostaglandin, intracavernosal injections, vacuum devices and penile prosthesis implantation have many advantages and disadvantages, and standard treatments models have indication differences. The recent studies on growth factors, immunophilines, gene and stem cell treatments are promising.

Özet

Radikal prostatektomi, organa sınırlı prostat kanserli olgularda altın standart tedavi olmasının yanında operasyon sonrası görülen erektil disfonksiyon olguların hayat kalitelerini ileri derecede bozmaktadır. Bu derlemede güncel literatür taranarak radikal prostatektomi sonrası görülen erektil disfonksi- yon, patofizyoloji, korunma ve kullanılan tedavi modaliteleri değerlendirildi. Uygun hasta, ileri cerrahi teknik operasyon sonrası görülen erektil disfonk- siyonun önlenmesinde önemlidir. Erken başlanılan rehabilitasyon programı erektil disfonksiyonun erken dönemde düzelmesini sağlamaktadır. Standart tedavi yöntemleri fosfodiesteraz 5 inhibitörleri, transüretral prostoglandin, intrakavernozal enjeksiyonlar, vakum cihazları ve penil protez implantasyonu gibi birbirleri arasında çeşitli avantaj, dezavantaj ve endikasyon farklılığı bulunan standart tedavi modelleri dışında büyüme faktörleri, immünofilinler, gen ve kök hücrelerle yapılan çalışmalar umut vericidir.

🔖

Cite This Article

AYDIN, M., ÖZKAN, A. (2012). After radical prostatectomy erectile dysfunction: approach and penile rehabilitation treatment modalities. JAREM, Cilt: 2 - Sayı: 3, 89–95. https://ajindex.com/articles/216327

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Partin AW, Mangold LA, Lamm DM, Walsh PC, Epstein JI, Pearson JD. Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium. Urology 2001
  2. [CrossRef] 2. Burnett AL, Aus G, Canby-Hagino ED, Cookson MS, D'Amico AV, Dmochowski RR, et al. Erectile function outcome reporting after cli- nically localized prostate cancer treatment. J Urol 2007
  3. [CrossRef] 3. Walsh PC, Donker PJ. Impotence following radical prostatectomy: insight into etiology and prevention. J Urol 1982
  4. Talcott JA, Rieker P, Propert KJ, Clark JA, Wishnow KI, Loughlin KR, et al. Patient-reported impotence and incontinence after nerve-sparing radical prostatectomy. J Natl Cancer Inst 1997
  5. [CrossRef] 5. Mulhall JP, Bella AJ, Briganti A, McCullough A, Brock G. Erectile function rehabilitation in the radical prostatectomy patient. J Sex Med 2010
  6. [CrossRef] 6. Chuang MS, O'Connor RC, Laven BA, Orvieto MA, Brendler CB. Early release of the neurovascular bundles and optical loupe mag- nification lead to improved and earlier return of potency following radical retropubic prostatectomy. J Urol 2005
  7. [CrossRef] 7. Carrier S, Zvara P, Nunes L, Kour NW, Rehman J, Lue TF. Regenera- tion of nitric oxide synthase-containing nerves after cavernous nerve neurotomy in the rat. J Urol 1995
  8. [CrossRef] 8. Zippe CD, Pahlajani G. Penile rehabilitation following radical pros- tatectomy: role of early intervention and chronic therapy. Urol Clin North Am 2007
  9. [CrossRef] 9. Akbal C, Şimşek F. Radikal prostatektomi sonrası erektil disfonksiyon önlenebilir mi? Cerrahi ve medikal alternatifler var mı? Üroonkoloji Bülteni 112-6. 10. Martin-Morales A, Sanchez-Cruz JJ, Saenz de Tejada I, Rodriguez- Vela L, Jimenez-Cruz JF, Burgos-Rodriguez R. Prevalence and inde- pendent risk factors for erectile dysfunction in Spain: results of the Epidemiologia de la Disfuncion Erectil Masculina Study. J Urol 2001
  10. [CrossRef] 11. Benet AE, Melman A. The epidemiology of erectile dysfunction. Urol Clin North Am 1995
  11. Whitehead ED, Klyde BJ. Diabetes-related impotence in the elderly. Clin Geriatr Med 1990
  12. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 1994
  13. Aboseif SR, Breza J, Orvis BR, Lue TF, Tanagho EA. Erectile